Low dose tezosentan, an intravenous dual endothelin receptor antagonist, decreases type B-natruretic peptide levels in patients with acute decompensated heart failure

✍ Scribed by Guillermo Torre-Amione; Edo Kaluski; Karl Stangl; Richard Pacher; Christoph Richter; Olga Milo; Loic Perchenet; Isaac Kobrin; Maurizio Rainision; Aline Frey; Eric Neuhart; Zvi Vered; Jasper Dingemanse; Gad Cotter

• Book ID: 119588589
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 75 KB
• Volume: 9
• Category: Article
• ISSN: 1532-8414
• DOI: 10.1016/s1071-9164(03)00334-8